Creative Medical Technology (CELZ) News Today $2.07 +0.07 (+3.50%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain TreatmentNovember 13, 2024 | globenewswire.comCreative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023)November 11, 2024 | uk.finance.yahoo.comCreative Medical Technology files to sell 837,104 shares of common for holdersNovember 10, 2024 | markets.businessinsider.comCreative Medical Technology files to sell 0.83M shares of common stocks by selling shareholdersNovember 10, 2024 | msn.comCreative Medical to sell 418,552 shares at $4.42 in registered direct offeringOctober 24, 2024 | finance.yahoo.comCreative Medical Technology to raise $1.9M via direct offeringOctober 23, 2024 | msn.comCreative Medical Tech (NASDAQ:CELZ) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comCreative Medical Tech (NASDAQ:CELZ) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comCreative Medical Technology files for $50M mixed securities shelfOctober 5, 2024 | msn.comCreative arts therapy programs can help health care workers through burnout and on-the-job stressAugust 30, 2024 | msn.comBrain-Imaging Experiment Reveals The Secret Behind Creative FlowAugust 16, 2024 | msn.comCELZ Stock Earnings: Creative Medical Tech Misses EPS for Q2 2024August 12, 2024 | investorplace.comCreative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine ProgramJuly 24, 2024 | globenewswire.comCreative Medical Technology Holdings Provides Corporate UpdateJuly 10, 2024 | globenewswire.comCreative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human InsulinJune 24, 2024 | globenewswire.comCreative Medical Technology Holdings Inc CELZApril 24, 2024 | morningstar.comCreative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 24, 2024 | finance.yahoo.comMedical Practices And Branding In A Digital AgeMarch 18, 2024 | forbes.comCreative Medical Technology Skyrockets on Word of New Diabetes MedicationMarch 18, 2024 | theglobeandmail.comWhy Is Diabetes Focused Creative Medical Stock Surging On Thursday?March 7, 2024 | msn.comCreative Medical Announces FDA Authorization For Expanded Access For CELZ-201; Stock UpMarch 7, 2024 | markets.businessinsider.comCreative Medical Shares Rise 37% After FDA Authorization for CELZ-201March 7, 2024 | marketwatch.comCreative Medical stock rallies for second day on FDA updatesMarch 7, 2024 | msn.comCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded AccessMarch 7, 2024 | finance.yahoo.comTrading was temporarily halted for "CELZ" at 09:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "CELZ" at 09:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comCreative Medical Technology Holdings IncMarch 6, 2024 | morningstar.comCreative Medical Receives FDA Orphan Drug Designation For CELZ-101; Stock Up In Pre-marketMarch 6, 2024 | markets.businessinsider.comCreative Medical Shares Rally Premarket on FDA Orphan DesignationMarch 6, 2024 | marketwatch.comCreative Medical stock rallies 18% on FDA orphan drug designationMarch 6, 2024 | msn.comTrading was temporarily halted for "CELZ" at 12:03 PM with a stated reason of "LULD pause." Trading set to resume at 12:03 PM. March 6, 2024 | marketbeat.comCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation TherapyMarch 6, 2024 | businesswire.comCreative Medical Technology Holdings Inc (CELZ)February 15, 2024 | investing.comSteven L White's Net WorthFebruary 9, 2024 | benzinga.comTrading was temporarily halted for "CELZ" at 10:12 AM with a stated reason of "LULD pause." Trading set to resume at 10:12 AM. December 20, 2023 | marketbeat.comCreative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back PainDecember 20, 2023 | finance.yahoo.comTrading was temporarily halted for "CELZ" at 09:12 AM with a stated reason of "LULD pause."December 20, 2023 | marketbeat.comCreative Medical to initiate trial of lower back pain treatmentOctober 11, 2023 | msn.comCreative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell TherapyOctober 10, 2023 | markets.businessinsider.comCreative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back PainOctober 10, 2023 | finance.yahoo.comWhat Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy StockSeptember 22, 2023 | finance.yahoo.comCreative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back PainSeptember 19, 2023 | finance.yahoo.comWhat Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?August 24, 2023 | finance.yahoo.comWhat Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?August 23, 2023 | benzinga.comCreative Medical Technology regains Nasdaq listing complianceJune 28, 2023 | msn.comCreative Medical Technology Holdings Provides Corporate UpdateJune 12, 2023 | finance.yahoo.comCreative Medical Technology Announces $2 Million Share Repurchase ProgramJune 12, 2023 | finance.yahoo.comCreative Medical Technology Holdings announces reverse stock split to regain complianceJune 9, 2023 | msn.comCreative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy PlatformMay 31, 2023 | finance.yahoo.comCreative Medical Releases Data From StemSpine Procedure For Chronic Lower Back PainMay 18, 2023 | msn.com Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address AI breakthrough about to upend industry (Ad)Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing. I urge you to watch it now. CELZ Media Mentions By Week CELZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELZ News Sentiment▼0.000.59▲Average Medical News Sentiment CELZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELZ Articles This Week▼00▲CELZ Articles Average Week Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Spruce Biosciences News NKGen Biotech News Bright Green News GlycoMimetics News Minerva Neurosciences News NRx Pharmaceuticals News Cara Therapeutics News Acurx Pharmaceuticals News Marinus Pharmaceuticals News TherapeuticsMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELZ) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELZ Stock Alerts